Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : PNT2001
Therapeutic Area : Oncology
Study Phase : Preclinical
Sponsor : Point Biopharma
Deal Size : Undisclosed
Deal Type : Agreement
Eckert & Ziegler to Supply POINT Biopharma with Actinium-225
Details : Under the agreement, Eckert & Ziegler will provide predetermined amounts of GMP grade Ac-225 to POINT for use in the development of POINT’s pipeline of next generation Ac-225-based radioligands, including PSMA-targeted PNT2001 program.
Brand Name : PNT2001
Molecule Type : Large molecule
Upfront Cash : Undisclosed
April 04, 2023
Lead Product(s) : PNT2001
Therapeutic Area : Oncology
Highest Development Status : Preclinical
Sponsor : Point Biopharma
Deal Size : Undisclosed
Deal Type : Agreement
LOOKING FOR A SUPPLIER?
Reset All
